40803 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 05
00:59 UTC
|
EQBK
Equity Bancshares
|
◎ Target | firm only | Market Perform | $51.00→ $53.00+3.9% |
|
Sep 05
00:59 UTC
|
DOCU
Docusign
|
◎ Target | Karl Keirstead ★★★★☆ #578 | Neutral | $54.00→ $70.00+29.6% |
|
Sep 05
00:59 UTC
|
DOCU
Docusign
|
◎ Target | Matt Bullock ★★★☆☆ #1218 | Underperform | $58.00→ $64.00+10.3% |
|
Sep 05
00:59 UTC
|
DOCU
Docusign
|
◎ Target | Michael Turrin ★★★☆☆ #972 | Equal Weight | $55.00→ $60.00+9.1% |
|
Sep 05
00:59 UTC
|
DOCU
Docusign
|
◎ Target | Tyler Radke ★★★★★ #234 | Neutral | $54.00→ $72.00+33.3% |
|
Sep 05
00:59 UTC
|
DOCU
Docusign
|
◎ Target | Rishi Jaluria ★★★★☆ #844 | Sec→ r Perform | $55.00→ $70.00+27.3% |
|
Sep 05
00:59 UTC
|
DOCU
Docusign
|
◎ Target | Rob Owens ★★★★★ #7 | Neutral | $52.00→ $75.00+44.2% |
|
Sep 05
00:59 UTC
|
DOCU
Docusign
|
◎ Target | William Power ★★★★★ #310 | Neutral | $55.00→ $72.00+30.9% |
|
Sep 05
00:59 UTC
|
DOCU
Docusign
|
◎ Target | Josh Baer ★★★☆☆ #1285 | Equal Weight | $69.00→ $75.00+8.7% |
|
Sep 05
00:59 UTC
|
DLTR
Dollar Tree
|
◎ Target | Seth Sigman ★★★☆☆ #1906 | Overweight | $140.00→ $160.00+14.3% |
|
Sep 05
00:59 UTC
|
DG
Dollar General
|
◎ Target | Chris Graja ★★★★★ #240 | Buy | $165.00→ $170.00+3.0% |
|
Sep 05
00:59 UTC
|
CURV
Torrid
|
◎ Target | Lorraine Hutchinson ★★☆☆☆ #2789 | Buy | $2.25→ $2.70+20.0% |
|
Sep 05
00:59 UTC
|
CTRI
Centuri
|
◎ Target | Sherif El-Sabbahy ★★☆☆☆ #2784 | Underperform | $33.50→ $21.00-37.3% |
|
Sep 05
00:59 UTC
|
CS
Capstone Copper
|
◎ Target | firm only | Outperform | C$18.50→ C$19.00+2.7% |
|
Sep 05
00:59 UTC
|
CRST
Crest Nicholson
|
◎ Target | firm only | Hold | GBX 70→ GBX 58-17.1% |
|
Sep 05
00:59 UTC
|
CQP
Cheniere Energy Partners
|
◎ Target | Jeremy Tonet ★★★☆☆ #1444 | Underweight | $64.00→ $65.00+1.6% |
|
Sep 05
00:59 UTC
|
CPB
Campbell's
|
◎ Target | Nik Modi ★★★★☆ #735 | Sec→ r Perform | $21.00→ $19.00-9.5% |
|
Sep 05
00:59 UTC
|
CPB
Campbell's
|
◎ Target | Andrew Lazar ★★★★☆ #900 | Underweight | $19.00→ $18.00-5.3% |
|
Sep 05
00:59 UTC
|
CPB
Campbell's
|
◎ Target | Peter Grom ★★★★☆ #429 | Sell | $18.00→ $19.00+5.6% |
|
Sep 05
00:59 UTC
|
CIEN
Ciena
|
◎ Target | Joseph Cardoso ★★★☆☆ #1652 | Overweight | $635.00→ $605.00-4.7% |
|
Sep 05
00:59 UTC
|
CIEN
Ciena
|
◎ Target | Sean O'Loughlin ★★★☆☆ #1635 | Buy | $575.00→ $400.00-30.4% |
|
Sep 05
00:59 UTC
|
CIEN
Ciena
|
◎ Target | Mike Genovese not yet tracked | Buy | $720.00→ $525.00-27.1% |
|
Sep 05
00:59 UTC
|
CIEN
Ciena
|
◎ Target | Tim Long ★★★☆☆ #1563 | Overweight | $607.00→ $475.00-21.7% |
|
Sep 05
00:59 UTC
|
CIEN
Ciena
|
◎ Target | Meta Marshall ★★★★☆ #850 | Equal Weight | $490.00→ $425.00-13.3% |
|
Sep 05
00:59 UTC
|
CIEN
Ciena
|
◎ Target | David Vogt ★★★☆☆ #974 | Neutral | $508.00→ $394.00-22.4% |
|
Sep 05
00:59 UTC
|
CHWY
Chewy
|
◎ Target | David Bellinger ★★★☆☆ #1151 | Outperform | $40.00→ $32.00-20.0% |
|
Sep 05
00:59 UTC
|
CHWY
Chewy
|
◎ Target | Rick Patel ★★☆☆☆ #2618 | Outperform | $25.00→ $28.00+12.0% |
|
Sep 05
00:59 UTC
|
CHPT
ChargePoint
|
◎ Target | Ryan Pfingst ★☆☆☆☆ #3076 | Neutral | $6.00→ $8.00+33.3% |
|
Sep 05
00:59 UTC
|
BTG
B2Gold
|
◎ Target | firm only | Outperform | $7.25→ $7.50+3.4% |
|
Sep 05
00:59 UTC
|
BRK
Brooks Macdonald Group
|
◎ Target | firm only | Buy | GBX 1,600→ GBX 1,780+11.2% |
|
Sep 05
00:59 UTC
|
BOY
Bodycote
|
◎ Target | firm only | Hold | GBX 900→ GBX 933+3.7% |
|
Sep 05
00:59 UTC
|
ASAN
Asana
|
◎ Target | Taylor McGinnis ★★★★★ #41 | Neutral | $8.00→ $10.00+25.0% |
|
Sep 05
00:59 UTC
|
ASAN
Asana
|
◎ Target | Rishi Jaluria ★★★★☆ #844 | Sec→ r Perform | $8.00→ $9.50+18.8% |
|
Sep 05
00:59 UTC
|
ASAN
Asana
|
◎ Target | Billy Fitzsimmons ★★★★★ #264 | Neutral | $7.00→ $9.00+28.6% |
|
Sep 05
00:59 UTC
|
ASAN
Asana
|
◎ Target | Lucky Schreiner ★★★★★ #316 | Neutral | $8.00→ $9.00+12.5% |
|
Sep 05
00:59 UTC
|
ASAN
Asana
|
◎ Target | Rob Oliver not yet tracked | Neutral | $9.00→ $10.00+11.1% |
|
Sep 05
00:59 UTC
|
AMGN
Amgen
|
◎ Target | Mohit Bansal ★★★☆☆ #1271 | Equal Weight | $400.00→ $435.00+8.8% |
|
Sep 05
00:59 UTC
|
AMBA
Ambarella
|
◎ Target | Suji Desilva ★★☆☆☆ #2729 | Neutral | $90.00→ $65.00-27.8% |
|
Sep 05
00:59 UTC
|
AMBA
Ambarella
|
◎ Target | Tore Svanberg ★★☆☆☆ #2457 | Buy | $106.00→ $90.00-15.1% |
|
Sep 05
00:59 UTC
|
AMBA
Ambarella
|
◎ Target | Vivek Arya ★★☆☆☆ #2658 | Neutral | $96.00→ $70.00-27.1% |
|
Sep 05
00:59 UTC
|
AKAM
Akamai Technologies
|
◎ Target | Fatima Boolani ★★★★★ #92 | Neutral | $160.00→ $122.00-23.8% |
|
Sep 05
00:59 UTC
|
AEP
Anglo-Eastern Plantations
|
◎ Target | firm only | Buy | GBX 250→ GBX 275+10.0% |
|
Sep 05
00:59 UTC
|
AEM
Agnico Eagle Mines
|
◎ Target | firm only | Outperform | $230.00→ $225.00-2.2% |
|
Sep 04
19:58 UTC
|
ZGN
Ermenegildo Zegna
|
◎ Target | Chris Huang not yet tracked | Buy | $15.40→ $15.50+0.6% |
|
Sep 04
19:58 UTC
|
OXM
Oxford Industries
|
◎ Target | Dana Telsey ★★★☆☆ #1298 | Market Perform | $44.00→ $35.00-20.5% |
|
Sep 04
19:58 UTC
|
AMGN
Amgen
|
◎ Target | Mohit Bansal ★★★☆☆ #1271 | Equal Weight | $400.00→ $435.00+8.8% |
|
Sep 04
18:58 UTC
|
TEVA
Teva Pharmaceutical Industries
|
◎ Target | Ashwani Verma ★★★★☆ #381 | Buy | $42.00→ $48.00+14.3% |
|
Sep 04
18:58 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Salveen Richter ★★★☆☆ #1429 | Neutral | $28.00→ $19.00-32.1% |
|
Sep 04
18:58 UTC
|
PATH
UiPath
|
◎ Target | Raimo Lenschow ★★★★☆ #350 | Equal Weight | $14.00→ $17.00+21.4% |
|
Sep 04
18:58 UTC
|
NUTX
Nutex Health
|
◎ Target | Anderson Schock ★★★★☆ #597 | Buy | $290.00→ $325.00+12.1% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.